The jewelry company Pandora has issued a press release regarding their quarterly results with the comments below from the new CEO and the CFO. Alexander Lacik, CEO: “I’m very excited to join Pandora. We have some very strong fundamentals in terms of a world-class supply chain, a strong product proposition as well as a deep …
Continue reading “The Pandora turnaround postponed until 2020?”
Press releases regarding first quarter results have been issued from diabetes competitors Novo Nordisk, Eli Lilly, Sanofi and others. Four of the main antidiabetic drug types manufactured by these pharmaceutical companies are insulin, GLP-1 receptor agonists, SGLT2 inhibitors (gliflozins) and DPP4 inhibitors (gliptins). The development in each of the four drug categories is covered in …
Continue reading “Diabetes developments in the first quarter of 2019”
Teva reported on their first quarter results and issued the following press release with the following headlines and statements from the CEO: – Revenues of $4.3 billion – GAAP diluted loss per share of $0.10 – Non-GAAP diluted EPS of $0.60 – Free cash flow of $360 million – Spend base reduction of $2.5 billion …